Mobile Applications for the Early Detection of Retinoblastoma: A Comprehensive Review - Report - MDSpire

Mobile Applications for the Early Detection of Retinoblastoma: A Comprehensive Review

  • By

  • Kartiekasari Syahidda Mohammad Zubairi

  • Ernie Zuraida Ali

  • Julaina Abdul Jalil

  • Chan Li Yen

  • Sangeetha Tharmathurai

  • Jamalia Rahmat

  • Mohd Khairul Nizam Mohd Khalid

  • February 11, 2026

  • 0 min

Share

Clinical Report: Mobile Applications for the Early Detection of Retinoblastoma

Overview

This comprehensive review evaluates the role of mobile applications in the early detection of retinoblastoma, highlighting their potential to improve screening accessibility. The findings suggest that while these apps can assist in identifying early signs, they should complement, not replace, traditional clinical screening methods.

Background

Retinoblastoma is a critical pediatric ocular malignancy that requires prompt diagnosis to improve survival rates. Delays in diagnosis, particularly in low-income countries, contribute to advanced disease at presentation, underscoring the need for effective early detection strategies. Mobile applications offer a promising avenue for enhancing awareness and facilitating earlier screening among caregivers and healthcare providers.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • Retinoblastoma is primarily caused by mutations in the RB1 gene or MYCN oncogene amplification.
  • Early signs of retinoblastoma include leukocoria and strabismus, often first noticed by parents or caregivers.
  • Delays in diagnosis can be significant, with median intervals from symptom onset to specialist consultation varying widely by region.
  • Mobile applications can assist in the early detection of leukocoria but are not substitutes for professional screening.
  • Existing smartphone apps for retinoblastoma screening show variable validation and effectiveness.

Clinical Implications

Healthcare professionals should consider integrating mobile applications as adjunct tools for early detection of retinoblastoma, particularly in enhancing parental awareness. However, reliance solely on these apps should be avoided, and traditional clinical assessments must remain the standard for diagnosis.

Conclusion

Mobile applications represent a valuable resource in the early detection of retinoblastoma, but they should be used in conjunction with established clinical practices to ensure timely and accurate diagnosis.

References

  1. Retinal Physician, 2018 -- NEW PRODUCT APPLICATIONS: Mobile App Enables Patients to Self-Monitor Vision Changes
  2. Retinal Physician, 2023 -- Cell-free DNA in Noninvasive Diagnosis of Retinoblastoma
  3. European Radiology, 2025 -- Updated Recommendations for Retinoblastoma Imaging: Insights from the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma Group, 2025 Edition
  4. RANZCO -- The Royal Australian and New Zealand College
  5. PAHO/WHO, 2025 -- New PAHO guide aims to improve early detection and survival rates of childhood cancer in Latin America and the Caribbean
  6. Ophthalmology Management — AI Advances for Diabetic Retinopathy
  7. RANZCO The Royal Australian and New Zealand Colleg
  8. Checking your browser - reCAPTCHA
  9. New PAHO guide aims to improve early detection and survival rates of childhood cancer in Latin America and the Caribbean - PAHO/WHO | Pan American Health Organization

Original Source(s)

Related Content